c ebpβ-lip

c ebpβ-lip drug Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer c ebpβ-lip drug Facts Continuous

Name: c ebpβ-lip drug Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer c ebpβ-lip drug Facts Continuous
Brand: iglepidom.org
SKU: 58653796515
Price: 23.61 USD
Availability: InStock
Rating: 4.3708 (25 reviews)

c ebp lip drug Facts Continuous Activation of C EBP Transcription The m6A demethylase FTO promotes C EBPLIP translation to perform oncogenic functions in breast cancer cells Zuidhof 2025 The FEBS Journal Wiley Online Library Purified anti C EBP beta 3 isoforms C EBP beta, LAP, LIP Antibody anti C EBP beta 1H7 P53 regulates CCAAT Enhancer binding protein gene expression ScienceDirect

SKU: 58653796515 · From iglepidom.org

4.4

USD23.61 USD67.61

Pay in 4 interest-free payments of $5.90 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 7 - Aug 12

Description

doi: 10.1186/1756-8722-7-14

c ebp-lip drug Increasing intratumor C/EBP- LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer c ebp-lip drug Facts Continuous

Additionally, we look at the impact of cannabinoids in neuronal circuits impacting the hypothalamic-pituitary hormonal axis, such as the locus coeruleus and raphe nuclei and their possible consequences on the cytochrome P450 system